InsiderTrades.com logo

RCUS Insider Trading

Insider Ownership Percentage: 9.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $10,092,282.74

Arcus Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Arcus Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arcus Biosciences Share Price & Price History

Current Price: $21.40
Price Change: ▲ Price Increase of +0.193 (0.91%)
As of 03/27/2026 10:30 AM ET

This chart shows the closing price history over time for RCUS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Arcus Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2026Juan C. JaenPresidentSell31,823$21.41$681,330.43922,240View SEC Filing Icon  
12/31/2025Robert C Goeltz IICFOSell6,552$23.38$153,185.7667,924View SEC Filing Icon  
12/18/2025Alexander AzoyCAOSell4,343$22.25$96,631.7518,531View SEC Filing Icon  
12/17/2025Alexander AzoyCAOSell2,113$22.16$46,824.0822,874View SEC Filing Icon  
12/17/2025Carolyn C TangGeneral CounselSell6,810$22.16$150,909.60124,734View SEC Filing Icon  
12/17/2025Jennifer JarrettCOOSell9,983$22.16$221,223.28193,024View SEC Filing Icon  
12/17/2025Juan C. JaenPresidentSell9,983$22.16$221,223.28346,012View SEC Filing Icon  
12/17/2025Richard MarkusInsiderSell4,494$22.16$99,587.0465,647View SEC Filing Icon  
12/17/2025Robert C Goeltz IICFOSell5,960$22.16$132,073.6074,476View SEC Filing Icon  
12/17/2025Terry J. RosenCEOSell25,744$22.16$570,487.042,194,809View SEC Filing Icon  
12/16/2025Alexander AzoyCAOSell2,376$21.88$51,986.8824,987View SEC Filing Icon  
12/16/2025Carolyn C TangGeneral CounselSell7,658$21.88$167,557.04131,544View SEC Filing Icon  
12/16/2025Jennifer JarrettCOOSell11,225$21.88$245,603.00203,007View SEC Filing Icon  
12/16/2025Juan C. JaenPresidentSell11,225$21.88$245,603.00355,995View SEC Filing Icon  
12/16/2025Richard MarkusInsiderSell5,052$21.88$110,537.7670,141View SEC Filing Icon  
12/16/2025Robert C Goeltz IICFOSell6,702$21.88$146,639.7680,436View SEC Filing Icon  
12/16/2025Terry J. RosenCEOSell28,947$21.88$633,360.362,220,553View SEC Filing Icon  
12/4/2025Juan C. JaenPresidentSell82,997$24.71$2,050,855.87954,063View SEC Filing Icon  
11/26/2025Alexander AzoyCAOSell1,900$26.00$49,400.0027,363View SEC Filing Icon  
11/18/2025Juan C. JaenPresidentSell5,050$19.75$99,737.501,037,060View SEC Filing Icon  
11/17/2025Juan C. JaenPresidentSell44,950$20.31$912,934.501,042,110View SEC Filing Icon  
10/30/2025Juan C. JaenPresidentSell4,314$20.32$87,660.481,087,060View SEC Filing Icon  
10/29/2025Juan C. JaenPresidentSell77,840$20.90$1,626,856.001,091,374View SEC Filing Icon  
10/28/2025Juan C. JaenPresidentSell19,019$20.19$383,993.611,169,214View SEC Filing Icon  
10/28/2025Robert C Goeltz IICFOSell5,000$20.00$100,000.0092,138View SEC Filing Icon  
10/8/2025Jennifer JarrettCOOSell37,792$15.05$568,769.60214,232View SEC Filing Icon  
10/6/2025Jennifer JarrettCOOSell12,500$14.54$181,750.00214,232View SEC Filing Icon  
9/29/2025Alexander AzoyCAOSell2,831$13.00$36,803.0027,363View SEC Filing Icon  
9/5/2025Alexander AzoyCAOSell1,579$11.88$18,758.5230,194View SEC Filing Icon  
2/27/2025Terry J. RosenCEOBuy19,800$10.18$201,564.002,554,160View SEC Filing Icon  
2/27/2025Yasunori KanekoDirectorBuy20,000$10.06$201,200.0028,400View SEC Filing Icon  
12/31/2024Robert C Goeltz IICFOSell3,594$15.00$53,910.0060,138View SEC Filing Icon  
12/2/2024Alexander AzoyCAOSell201$15.32$3,079.3219,070View SEC Filing Icon  
3/27/2024Jennifer JarrettCOOSell11,551$17.55$202,720.05215,253View SEC Filing Icon  
3/18/2024Jennifer JarrettCOOSell13,449$17.92$241,006.08226,804View SEC Filing Icon  
2/26/2024Jennifer JarrettCOOSell24,555$20.07$492,818.85274,323View SEC Filing Icon  
2/26/2024Juan C. JaenPresidentSell3,900$20.06$78,234.001,211,365View SEC Filing Icon  
1/29/2024Gilead Sciences, Inc.Major ShareholderBuy15,238,095$21.00$319,999,995.0030,061,124View SEC Filing Icon  
1/2/2024Juan C. JaenPresidentSell6,975$20.09$140,127.751,215,265View SEC Filing Icon  
1/2/2024Robert C Goeltz IICFOSell2,004$20.00$40,080.0051,831View SEC Filing Icon  
12/22/2023Jennifer JarrettCOOSell21,521$17.76$382,212.96258,878View SEC Filing Icon  
9/22/2023Jennifer JarrettCOOSell21,369$19.99$427,166.31302,691View SEC Filing Icon  
7/28/2023Jennifer JarrettCOOSell45,000$20.25$911,250.00336,566View SEC Filing Icon  
7/3/2023Alexander AzoyCAOSell1,018$20.41$20,777.3811,596View SEC Filing Icon  
6/28/2023Gilead Sciences, Inc.Major ShareholderBuy1,010,000$19.26$19,452,600.0014,823,029View SEC Filing Icon  
6/22/2023Jennifer JarrettCOOSell12,437$19.12$237,795.44381,566View SEC Filing Icon  
6/16/2023Jennifer JarrettCOOSell12,563$19.35$243,094.05394,003View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Arcus Biosciences (NYSE:RCUS)

92.89% of Arcus Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RCUS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arcus Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.12,224$0.29M0.0%+217.0%0.010%Search for SEC Filing on Google Icon
2/19/2026T. Rowe Price Investment Management Inc.1,625$39K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.414,365$9.87M0.0%+41.7%0.384%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury34,855$0.83M0.0%+34.2%0.032%Search for SEC Filing on Google Icon
2/18/2026VestGen Advisors LLC27,152$0.65M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP5,184,509$123.55M0.0%+309.4%4.802%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.29,143$0.69M0.0%+66.0%0.027%Search for SEC Filing on Google Icon
2/18/2026Toronto Dominion Bank1,484,699$35.38M0.1%N/A1.375%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL208,639$4.97M0.0%N/A0.193%Search for SEC Filing on Google Icon
2/18/2026Suvretta Capital Management LLC5,188,858$123.65M2.5%+40.7%4.806%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC168,876$4.02M0.0%-73.4%0.156%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC42,338$1.01M0.0%+36.4%0.039%Search for SEC Filing on Google Icon
2/18/2026Baker BROS. Advisors LP270,000$6.43M0.0%N/A0.250%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC97,283$2.32M0.0%+99.0%0.090%Search for SEC Filing on Google Icon
2/17/2026Burkehill Global Management LP50,000$1.19M0.1%N/A0.046%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC86,207$2.05M0.0%+2.9%0.080%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD58,649$1.40M0.0%+18.9%0.054%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP180,000$4.29M0.2%N/A0.167%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System90,666$2.16M0.0%+41.7%0.084%Search for SEC Filing on Google Icon
2/17/2026Fort Baker Capital Management LP52,523$1.25M0.1%N/A0.049%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.136,121$3.24M0.0%+65.5%0.126%Search for SEC Filing on Google Icon
2/17/2026Maryland State Retirement & Pension System12,381$0.30M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/17/2026Granahan Investment Management LLC169,940$4.05M0.2%-62.7%0.157%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board58,835$1.40M0.0%+91.5%0.054%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC44,758$1.07M0.0%N/A0.041%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada4,151$99K0.0%-89.9%0.004%Search for SEC Filing on Google Icon
2/16/2026Sofinnova Investments Inc.1,096,705$26.13M1.1%-10.3%1.016%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC21,056$0.50M0.0%-52.5%0.020%Search for SEC Filing on Google Icon
2/16/2026Nicholas Investment Partners LP204,338$4.87M0.4%N/A0.189%Search for SEC Filing on Google Icon
2/16/2026First Turn Management LLC565,142$13.47M1.5%N/A0.523%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP3,387,794$80.73M0.1%N/A3.138%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 41,993$1M0.0%+19.9%0.039%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co73,862$1.76M0.0%+24.7%0.068%Search for SEC Filing on Google Icon
2/13/2026Affinity Asset Advisors LLC300,000$7.15M0.4%N/A0.278%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP240,000$5.72M0.0%-29.4%0.222%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.929,981$22.16M0.1%-17.0%0.861%Search for SEC Filing on Google Icon
2/13/2026Public Sector Pension Investment Board295,426$7.04M0.0%+9.5%0.274%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC92,929$2.21M0.0%+33.4%0.086%Search for SEC Filing on Google Icon
2/13/2026Alyeska Investment Group L.P.142,518$3.40M0.0%N/A0.132%Search for SEC Filing on Google Icon
2/13/2026Siren L.L.C.3,007,077$71.66M2.1%+3.3%2.785%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.968,241$23.07M0.0%+11.1%0.897%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey21,047$0.50M0.0%+12.0%0.019%Search for SEC Filing on Google Icon
2/13/2026State Street Corp4,576,969$109.07M0.0%+34.8%4.239%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC144,093$3.43M0.0%+64.2%0.133%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN99,318$2.37M0.0%+45.4%0.092%Search for SEC Filing on Google Icon
2/13/2026Platinum Investment Management Ltd.134,217$3.20M0.7%-12.7%0.124%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC43,434$1.04M0.0%+4.8%0.040%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC32,700$0.78M0.0%-85.1%0.030%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP1,524,157$36.32M0.0%+1.4%1.412%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.23,219$0.55M0.0%+1,378.0%0.022%Search for SEC Filing on Google Icon
2/12/2026Decheng Capital LLC541,559$12.91M1.7%-1.1%0.502%Search for SEC Filing on Google Icon
2/12/2026Patient Square Capital LP170,000$4.05M0.9%N/A0.157%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund43,002$1.03M0.0%+96.8%0.040%Search for SEC Filing on Google Icon
2/12/2026Knott David M Jr121,241$2.89M1.3%+27.4%0.112%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank167,996$4M0.0%+25.8%0.156%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC141,600$3.37M0.0%+11.6%0.131%Search for SEC Filing on Google Icon
2/11/2026Inceptionr LLC8,811$0.21M0.1%N/A0.008%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG62,652$1.49M0.0%+29.6%0.058%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC24,211$0.58M0.0%+5.7%0.022%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.853,491$20.34M0.0%N/A0.790%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd62,251$1.48M0.1%-32.5%0.058%Search for SEC Filing on Google Icon
2/11/2026Parallel Advisors LLC86,557$2.06M0.0%-1.6%0.080%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.1,168,437$27.84M0.0%+22.9%1.082%Search for SEC Filing on Google Icon
2/10/2026Commonwealth of Pennsylvania Public School Empls Retrmt SYS21,135$0.50M0.0%+20.0%0.020%Search for SEC Filing on Google Icon
2/10/2026BNP Paribas Financial Markets424,071$10.11M0.0%+404.7%0.393%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC24,817$0.59M0.0%+25.1%0.023%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC1,907,345$45.46M0.0%+19.3%1.766%Search for SEC Filing on Google Icon
2/9/2026Fisher Asset Management LLC1,949,788$46.46M0.0%+167.4%1.806%Search for SEC Filing on Google Icon
2/9/2026Sectoral Asset Management Inc.56,945$1.36M1.1%-84.5%0.053%Search for SEC Filing on Google Icon
2/9/2026Legal & General Group Plc205,203$4.89M0.0%+15.0%0.190%Search for SEC Filing on Google Icon
2/9/2026Hantz Financial Services Inc.1,604$38K0.0%+121.9%0.001%Search for SEC Filing on Google Icon
2/6/2026Legato Capital Management LLC26,055$0.62M0.1%N/A0.024%Search for SEC Filing on Google Icon
2/6/2026Profund Advisors LLC39,639$0.95M0.0%+125.3%0.037%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC15,367$0.37M0.0%+18.3%0.014%Search for SEC Filing on Google Icon
2/5/2026Thrivent Financial for Lutherans80,393$1.92M0.0%+61.1%0.074%Search for SEC Filing on Google Icon
2/4/2026Oregon Public Employees Retirement Fund19,481$0.46M0.0%+25.0%0.018%Search for SEC Filing on Google Icon
2/4/2026VIRGINIA RETIREMENT SYSTEMS ET Al26,250$0.63M0.0%-4.5%0.024%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio16,800$0.40M0.0%N/A0.016%Search for SEC Filing on Google Icon
1/30/2026New York State Teachers Retirement System92,431$2.20M0.0%+1.1%0.086%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D29,071$0.69M0.0%N/A0.027%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA11,462$0.27M0.0%N/A0.011%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG411,259$9.80M0.0%+145.7%0.381%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.7,962,874$189.76M0.0%+20.1%7.375%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System23,817$0.57M0.0%+16.9%0.022%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH34,619$0.83M0.0%N/A0.032%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 36,929$0.88M0.0%+46.4%0.034%Search for SEC Filing on Google Icon
1/27/2026Bayforest Capital Ltd7,968$0.19M0.1%N/A0.007%Search for SEC Filing on Google Icon
1/23/2026State of Alaska Department of Revenue43,451$1.04M0.0%+24.8%0.040%Search for SEC Filing on Google Icon
1/22/2026Massachusetts Financial Services Co. MA23,216$0.55M0.0%-3.2%0.022%Search for SEC Filing on Google Icon
1/21/2026Yousif Capital Management LLC23,207$0.51M0.0%+7.8%0.021%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc384,601$9.17M0.0%+16.0%0.356%Search for SEC Filing on Google Icon
1/16/2026Tema Etfs LLC36,125$0.86M0.1%+19.3%0.033%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC18,873$0.44M0.0%+9.6%0.017%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC45,488$1.08M0.0%+38.8%0.042%Search for SEC Filing on Google Icon
1/5/2026GAMMA Investing LLC3,230$77K0.0%+17.5%0.003%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.63,942$0.87M0.0%+5.4%0.059%Search for SEC Filing on Google Icon
12/15/2025Hudson Bay Capital Management LP340,000$4.62M0.0%-20.9%0.315%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.1,120,062$15.23M0.1%+39.1%1.037%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP3,769,684$51.27M0.2%-5.8%3.491%Search for SEC Filing on Google Icon
11/17/2025PDT Partners LLC388,338$5.28M0.3%-0.2%0.360%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arcus Biosciences logo
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's pipeline products include Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial; and AB308, an investigational anti-TIGIT monoclonal antibody, which is in Phase 1b clinical trial to study people with advanced solid and hematologic malignancies. It also develops Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in Phase 2 clinical trial; Quemliclustat, a small-molecule CD73 inhibitor, which is Phase 1b and Phase 2 clinical trial; Zimberelimab, an anti-PD-1 antibody, which is in Phase 2 clinical trial for metastatic cell lung cancer and monotherapy; and AB521, an oral and small-molecule inhibitor of HIF-2a, which is in Phase 1 clinical trial for the treatment of Von Hippel-Lindau disease. In addition, the company's preclinical pipeline products include AB598, a CD39 antibody; and AB801, a small molecule Axl inhibitor. It has a clinical collaboration with AstraZeneca to evaluate domvanalimab in combination with durvalumab in a registrational phase 3 clinical trial in patients with unresectable Stage 3 NSCLC; and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is headquartered in Hayward, California.
Read More on Arcus Biosciences

Today's Range

Now: $21.40
Low: $20.95
High: $20.95

50 Day Range

MA: $21.44
Low: $18.76
High: $24.48

52 Week Range

Now: $21.40
Low: $6.50
High: $26.40

Volume

12,798 shs

Average Volume

1,240,368 shs

Market Capitalization

$2.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85

Who are the company insiders with the largest holdings of Arcus Biosciences?

Arcus Biosciences' top insider shareholders include:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Gilead Sciences Inc (Major Shareholder)
  3. Terry J Rosen (CEO)
  4. Juan C Jaen (President)
  5. Jennifer Jarrett (COO)
  6. Carolyn C Tang (General Counsel)
  7. Robert C Goeltz II (CFO)
  8. Kathryn E Falberg (Director)
  9. Richard Markus (Insider)
  10. Alexander Azoy (CAO)
Learn More about top insider investors at Arcus Biosciences.

Who are the major institutional investors of Arcus Biosciences?

Arcus Biosciences' top institutional shareholders include:
  1. Vanguard Group Inc. — 7.38%
  2. Suvretta Capital Management LLC — 4.81%
  3. Wellington Management Group LLP — 4.80%
  4. State Street Corp — 4.24%
  5. Marshall Wace LLP — 3.14%
  6. Siren L.L.C. — 2.79%
Learn More about top institutional investors of Arcus Biosciences stock.

Which major investors are selling Arcus Biosciences stock?

In the previous quarter, RCUS stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Sectoral Asset Management Inc.
  3. Granahan Investment Management LLC
  4. Jacobs Levy Equity Management Inc.
  5. Renaissance Technologies LLC
  6. Sofinnova Investments Inc.
  7. Hudson Bay Capital Management LP
  8. Royal Bank of Canada
Within the previous year, company insiders that have sold Arcus Biosciences company stock include:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Gilead Sciences Inc (Major Shareholder)
  3. Terry J Rosen (CEO)
  4. Juan C Jaen (President)
  5. Jennifer Jarrett (COO)
  6. Carolyn C Tang (General Counsel)
  7. Robert C Goeltz II (CFO)
Learn More investors selling Arcus Biosciences stock.

Which major investors are buying Arcus Biosciences stock?

During the previous quarter, RCUS stock was bought by institutional investors including:
  1. Wellington Management Group LLP
  2. Marshall Wace LLP
  3. Suvretta Capital Management LLC
  4. Toronto Dominion Bank
  5. Vanguard Group Inc.
  6. Fisher Asset Management LLC
  7. State Street Corp
  8. Franklin Resources Inc.
During the previous year, these company insiders have bought Arcus Biosciences stock:
  1. Gilead Sciences, Inc (Major Shareholder)
  2. Gilead Sciences Inc (Major Shareholder)
Learn More investors buying Arcus Biosciences stock.

Arcus Biosciences Active Insiders

Terry J Rosen
Terry J Rosen (Age 66)
CEO
2 recent trades
Juan C Jaen
Juan C Jaen (Age 68)
President
9 recent trades
Jennifer Jarrett
Jennifer Jarrett (Age 55)
COO
4 recent trades
Robert C Goeltz II
Robert C Goeltz II (Age 53)
CFO
4 recent trades
Alexander Azoy
Alexander Azoy (Age 50)
CAO
5 recent trades
Yasunori Kaneko
Yasunori Kaneko
Director
Carolyn C Tang
Carolyn C Tang
General Counsel
2 recent trades
Richard Markus
Richard Markus
Insider
2 recent trades